{"id":4899,"date":"2025-09-30T10:18:31","date_gmt":"2025-09-30T00:18:31","guid":{"rendered":"\/eu-uk\/?p=4899"},"modified":"2025-09-30T10:20:33","modified_gmt":"2025-09-30T00:20:33","slug":"orthocell-appoints-first-distributor-for-remplir-in-us75m-canadian-market","status":"publish","type":"post","link":"\/eu-uk\/blog\/2025\/09\/30\/orthocell-appoints-first-distributor-for-remplir-in-us75m-canadian-market\/","title":{"rendered":"Orthocell Appoints First Distributor for Remplir\u2122 in US$75m Canadian Market"},"content":{"rendered":"

Orthocell has appointed its first Canadian distributor for Remplir\u2122, signalling the commencement of the Company\u2019s commercial roll out in the US$75m<\/span>\u00a0<\/span> Canadian nerve repair market.<\/span>\u00a0<\/span><\/p>\n

Following Health Canada\u2019s approval of the Medical Device Licence for Remplir in April, the Company has now secured exclusive distributorships for Alberta and British Columbia, with further appointments anticipated for additional provinces to ensure broad Canadian market coverage.\u00a0<\/span>\u00a0<\/span><\/p>\n

Official launch activities will commence in early October at the prestigious Annual Meeting of the American Society for Surgery of the Hand (ASSH) in Vancouver, which will be attended by Orthocell\u2019s commercial team.<\/span>\u00a0<\/span><\/p>\n

Orthocell CEO and MD, Paul Anderson said:\u00a0<\/span>\u00a0<\/span><\/p>\n

\u201cSecuring our first Canadian distributor provides immediate access to key provinces and will build Remplir\u2019s profile as a next-generation nerve repair solution. This is a major step in accelerating Remplir\u2019s international growth and our team is looking forward to supporting Canadian clinicians in delivering improved patient outcomes.\u00a0<\/span>\u00a0<\/span><\/p>\n

\u201cOur existing US Marketing and Medical Education teams are ideally placed to oversee our Canadian market entry given the significant crossover between jurisdictions with many surgeons operating in both countries.<\/span>\u00a0<\/span><\/p>\n

\u201cWe expect to see early surgical cases commence in Canada late this year.\u201d<\/span>\u00a0<\/span><\/p>\n

Click to read the ASX release.<\/span>\u00a0<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Orthocell has appointed its first Canadian distributor for Remplir\u2122, signalling the commencement of the Company\u2019s commercial roll out in the US$75m\u00a0 Canadian nerve repair market.\u00a0<\/p>\n","protected":false},"author":2,"featured_media":4852,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4899","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t